April 17, 2018 / 6:00 PM / 3 months ago

U.S. drug agency to propose rules to rein in opioid manufacturing

WASHINGTON, April 17 (Reuters) - The U.S. Drug Enforcement Administration on Tuesday unveiled plans to rein in the amount of opioids that can be manufactured by drug makers in a given year, in an effort to combat the deadly opioid epidemic that has plagued the United States.

The DEA’s proposed changes to its regulations over addictive drug manufacturing quotas are expected to be formally announced by Attorney General Jeff Sessions in a speech on Tuesday. (Reporting by Sarah N. Lynch, editing by G Crosse)

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below